KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Land & Improvements (2016 - 2025)

Historic Land & Improvements for Healthcare (HCA) over the last 16 years, with Q4 2025 value amounting to $3.4 billion.

  • Healthcare's Land & Improvements rose 364.19% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 364.19%. This contributed to the annual value of $3.4 billion for FY2025, which is 364.19% up from last year.
  • Per Healthcare's latest filing, its Land & Improvements stood at $3.4 billion for Q4 2025, which was up 364.19% from $3.3 billion recorded in Q4 2024.
  • In the past 5 years, Healthcare's Land & Improvements ranged from a high of $3.4 billion in Q4 2025 and a low of $2.5 billion during Q4 2021
  • Moreover, its 5-year median value for Land & Improvements was $3.1 billion (2023), whereas its average is $3.0 billion.
  • As far as peak fluctuations go, Healthcare's Land & Improvements soared by 1213.94% in 2022, and later skyrocketed by 364.19% in 2025.
  • Healthcare's Land & Improvements (Quarter) stood at $2.5 billion in 2021, then grew by 12.14% to $2.8 billion in 2022, then rose by 11.47% to $3.1 billion in 2023, then grew by 5.61% to $3.3 billion in 2024, then increased by 3.64% to $3.4 billion in 2025.
  • Its Land & Improvements stands at $3.4 billion for Q4 2025, versus $3.3 billion for Q4 2024 and $3.1 billion for Q4 2023.